GKB Ophthalmics Ltd533212Corporate

Medical Equipment & Supplies Latest results: Jun 2026 14 quarters of data

₹62.50

MCap ₹32 Cr

GKB Ophthalmics Ltd — Stock analysis & AI research GKB Ophthalmics Ltd — Live exchange announcements

AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.

₹6 Cr

Sales · Jun 2026

-27.0% YoY

₹-0 Cr

Operating Profit · Jun 2026

+69.8% YoY

-4.0%

OPM % · Jun 2026

+58.8% YoY

₹-1 Cr

Net Profit · Jun 2026

+76.5% YoY

₹-1.00

EPS · Jun 2026

+76.5% YoY

📝 GKB Ophthalmics Ltd — results explained

Quarter ended June 2026 (Q1 FY27)

GKB Ophthalmics Ltd reported revenue of ₹6 crore for the quarter ended June 2026 (Q1 FY27), down 27.0% from ₹9 crore in the same quarter last year, and down 0.0% sequentially over the March 2026 quarter.

The company reported a net loss of ₹1 crore, against a net loss of ₹2 crore in the same quarter last year. Earnings per share (EPS) came in at ₹-1.00.

Operating profit stood at ₹-0 crore — an operating margin (OPM) of -4.0%, compared with -9.7% in the year-ago quarter.

Full year and trailing twelve months

For the full year FY26, GKB Ophthalmics Ltd posted revenue of ₹26 crore, a decline of 21.7% over FY25, with a net loss of ₹4 crore.

On a trailing-twelve-month (TTM) basis, revenue stands at ₹23 crore with a net loss of ₹2 crore.

Valuation snapshot

At the current price of ₹62.50, 533212 has a market capitalisation of ₹32 crore.

Within the Medical Equipment & Supplies industry, it is the 11th-largest of the 13 companies we track by market value.

Shareholding pattern

As of Jun 2026, promoters held 51.15%, foreign institutional investors (FIIs) 1.79%, public shareholders 47.07% of GKB Ophthalmics Ltd.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close

Valuation

Market Cap ?

₹32 Cr

Current Price ?

₹62.5

P/E ?

N/A

Industry P/E ?

26.90

P/B ?

2.25

P/S ?

1.39

P/FCF ?

-15.66

Enterprise Value ?

₹42 Cr

EV/EBITDA ?

-17.51

PEG ?

N/A

Earnings Yield ?

-12.1%

Dividend Yield ?

0.00%

Profitability & Returns

Sales (TTM) ?

₹23 Cr

OPM ?

-10.3%

Profit after tax (TTM) ?

₹-2 Cr

EPS (TTM) ?

₹-3.72

ROCE ?

1.0%

ROE ?

-13.4%

ROA ?

-5.3%

Growth

Sales — latest qtr ?

₹6 Cr

PAT — latest qtr ?

₹-1 Cr

YoY qtr sales growth ?

-27.0%

YoY qtr profit growth ?

76.5%

Sales growth (3y) ?

-3%

Sales growth (5y) ?

Profit growth (3y) ?

12%

Profit growth (5y) ?

-18%

Financial Health

Debt ?

₹10 Cr

Debt to Equity ?

0.67

Interest Coverage ?

-2.6

Current Ratio ?

N/A

Ownership

Promoter holding ?

51.15%

Change in promoter holding ?

0.09%

Pledged percentage ?

N/A

Market

Return 3 months ?

-1.0%

Return 6 months ?

7.1%

🗓️ Quarterly results (14 quarters · ₹ Cr)

same fiscal quarter as Jun bestweakest per row · for costs (interest, NPAs) low is best Highlight

Metric	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	YoY %	QoQ %
Sales	6	10	7	7	7	9	8	7	8	9	6	4	6	6	-27.0%	-0.0%
Operating Profit	-1	1	-1	-1	-0	-0	-1	-1	-1	-1	-1	-1	-0	-0	+69.8%	+43.0%
Other Income	0	0	0	2	0	0	0	2	0	0	1	3	-0	0	+576.4%	+194.7%
Interest	0	0	0	0	0	0	0	0	1	1	1	1	0	0	-56.1%	-6.7%
Depreciation	2	1	1	1	1	1	1	1	1	1	1	1	1	1	-1.9%	-0.4%
Profit Before Tax	-2	0	-2	-0	-1	-1	-2	-0	-2	-2	-1	1	-2	-1	+65.3%	+61.7%
Net Profit	-2	0	-2	-0	-1	-1	-2	-0	-2	-2	-1	1	-2	-1	+76.5%	+73.3%
EPS	-4.21	0.16	-3.59	-0.62	-2.72	-2.80	-4.07	-0.34	-4.92	-4.25	-1.03	1.94	-3.73	-1.00	+76.5%	+73.2%
OPM %	-7.9%	10.2%	-11.7%	-14.8%	-5.6%	-5.0%	-12.6%	-11.0%	-14.0%	-9.7%	-10.3%	-24.1%	-7.0%	-4.0%	+58.8%	+42.9%

📆 Annual results (₹ Cr, FY = Apr–Mar)

Metric	FY25	FY26	TTM	YoY %
Sales	₹33 Cr	₹26 Cr	₹23 Cr	-21.7%
Operating Profit	₹-3 Cr	₹-3 Cr	₹-2 Cr	+14.1%
OPM %	-10.59%	-11.62%	-10.26%	-9.7%
NPM %	-18.65%	-13.88%	-8.26%	+25.6%
Other Income	₹2 Cr	₹4 Cr	₹5 Cr	+112.2%
Depreciation	₹3 Cr	₹3 Cr	₹3 Cr	+1.9%
Interest	₹2 Cr	₹2 Cr	₹2 Cr	+14.8%
EBIT	₹-6 Cr	₹-6 Cr	₹-5 Cr	+7.2%
PBT	₹-6 Cr	₹-4 Cr	₹-2 Cr	+39.3%
Tax	—	—	₹-0 Cr	—
Net Profit	₹-6 Cr	₹-4 Cr	₹-2 Cr	+41.7%
EPS	₹-12.13	₹-7.07	₹-3.82	+41.7%
Material Cost	—	—	₹3 Cr	—
Employee Cost	—	—	₹2 Cr	—
Extraordinary Items	—	—	—	—

🏛️ Balance Sheet (latest 4 periods)

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026	% Chg
Equity Capital	5.04	5.04	5.04	5.04	+0.0%
Reserves	22.48	18.95	12.63	9.28	-26.5%
Borrowings	11.22	11.08	18.09	9.53	-47.3%
Other Liabilities	10.41	13.32	13.72	12.75	-7.1%
Total Liabilities	49.15	48.39	49.48	36.60	-26.0%
Fixed Assets	17.28	15.89	14.44	12.49	-13.5%
CWIP	3.82	3.78	3.78	3.78	+0.0%
Investments	11.90	11.90	11.90	0.19	-98.4%
Other Assets	16.15	16.82	19.36	20.14	+4.0%
Total Assets	49.15	48.39	49.48	36.60	-26.0%

💧 Cash Flow (latest 4 periods)

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026	% Chg
Cash from Operating Activity	-1.14	1.36	-5.04	-1.48	+70.6%
Cash from Investing Activity	2.40	0.37	-0.16	12.21	+7731.2%
Cash from Financing Activity	-2.03	-1.74	5.12	-10.72	-309.4%
Net Cash Flow	-0.78	0.00	-0.07	0.00	+100.0%
Free Cash Flow	0.25	0.16	-6.43	-2.06	+68.0%
CFO/OP	101%	-107%	144%	49%	-66.0%

➗ Ratios (latest 4 periods)

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026	% Chg
Debtor Days	64.23	80.30	83.48	73.74	-11.7%
Inventory Days	161.81	102.38	120.22	143.13	+19.1%
Days Payable	139.11	157.83	137.81	139.26	+1.1%
Cash Conversion Cycle	86.93	24.86	65.88	77.61	+17.8%
Working Capital Days	-60.02	-85.22	-70.10	-34.17	+51.3%
ROCE %	-3.96%	-4.96%	-11.80%	1.04%	+108.8%

👥 Shareholding (latest 4 periods)

Metric	Sep 2025	Dec 2025	Mar 2026	Jun 2026	% Chg
Promoters	51.06%	51.13%	51.13%	51.15%	+0.0%
FIIs	1.79%	1.79%	1.79%	1.79%	+0.0%
Public	47.17%	47.09%	47.09%	47.07%	-0.0%
No. of Shareholders	2,601	2,661	2,634	2,557	-2.9%

⚖️ Peer comparison

Industry: Medical Equipment & Supplies · 13 companies · full page →

#	Company	CMP	MCap (Cr)	P/E	Sales TTM	NP TTM	OPM%	NPM%	Sales YoY%	NP YoY%	Qtr Rev Δ%	Qtr NP Δ%
1	FISCHER Fischer Medical	₹33.50	2,293	85.2	367	24	12.3%	6.7%	178.6%	2051.4%	249.4%	-24.3%
2	TARSONS Tarsons Products	₹330.00	1,756	157.9	441	11	27.0%	2.5%	-66.3%	-81.4%	20.7%	-181.0%
3	DENTALKART Vasa Denticity	₹563.10	977	80.0	299	12	4.4%	4.0%	16.7%	-28.5%	12.9%	-2.9%
4	543916 Hemant Surgical	₹193.85	544	13.9	231	18	10.4%	7.8%	—	—	187.9%	160.0%
5	543363 Prevest Denpro	₹616.50	456	32.8	75	23	35.7%	29.9%	13.6%	17.6%	23.7%	24.8%
6	QMSMEDI QMS Medical	₹185.89	359	52.7	162	7	13.1%	4.1%	5.1%	-47.9%	23.7%	-0.8%
7	NURECA Nureca	₹331.55	331	75.9	153	4	2.7%	2.8%	34.0%	146.7%	18.0%	277.2%
8	530427 Choksi Asia	₹65.64	122	7.2	47	5	14.5%	11.1%	61.1%	173.2%	-22.5%	-10.1%
9	527005 Shree Pacetronix	₹168.25	55	19.2	21	3	24.8%	15.3%	28.7%	324.3%	-8.3%	14.5%
10	544143 Royal Sense	₹139.00	47	24.7	38	3	12.8%	8.0%	—	—	2.5%	-5.4%
11	533212 GKB Ophthalmics	₹104.90	32	17.6	150	6	7.0%	3.7%	36.8%	142.7%	2.3%	388.5%
12	531380 Centenial Surgical	₹110.90	27	—	56	-1	10.7%	-2.6%	0.6%	-38.1%	18.6%	1937.8%
13	542765 Transpact Enterprises	₹325.00	4	140.1	0	0	63.2%	47.4%	—	—	12.5%	-20.0%

❓ Frequently asked questions

What was GKB Ophthalmics Ltd's revenue in Q1 FY27?

What was GKB Ophthalmics Ltd's net profit in Q1 FY27?